In conjunction with Napo Pharmaceuticals, Jaguar Health is a wholly-owned subsidiary that is focused on developing and commercializing a range of first-in-class gastrointestinal prescription products for humans and animals, as well as non-prescription gastrointestinal products for animals. The team at Jaguar Health is committed to identifying human and animal health market opportunities where they can develop targeted products that leverage their broad intellectual property portfolio, deep pipeline and extensive botanical library.